A Multi-Center, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Clinical Trial Evaluating the Safety of Reproxalap Ophthalmic Solution in Subjects With Dry Eye Disease
Trial details
- Registry ID
- NCT04735393
- Phase
- Phase 3
Drug identity checked against registry records
| No regulatory events match this view.This does not mean no FDA events have occurred. |